12/09/2009: ULURU INC. INVITED TO PRESENT ALTRAZEAL RESEARCH AT 10th ANNUAL WOUND HEALING SCIENCE AND INDUSTRY CONFERENCE
(Click here to read more)

12/03/2009: ULURU INC. OBTAINS STATUS OF APPROVED SUPPLIER WITH MCKESSON
(Click here to read more)

11/16/2009: ULURU INC. REPORTS THIRD QUARTER 2009 FINANCIAL RESULTS
(Click here to read more)

11/12/2009: ULURU INC. TO RAISE $1.5 MILLION IN REGISTERED DIRECT OFFERING
(Click here to read more)

10/22/2009: ULURU INC. ANNOUNCES POSTER PRESENTATION ON THE USE OF ALTRAZEAL™ IN HOME CARE
(Click here to read more)

10/21/2009: ULURU INC. ANNOUNCES EXTENSIVE CLINICAL EVIDENCE PRESENTED AT THE 24TH ANNUAL “CLINICAL SYMPOSIUM ON ADVANCES IN SKIN AND WOUND CARE”
(Click here to read more)

09/24/2009: ULURU INC. PRESENTS DATA ON NEGATIVE PRESSURE RELATED TO ALTRAZEAL™ AT THE DIABETIC LIMB SALVAGE CONFERENCE IN WASHINGTON, D.C.
(Click here to read more)

09/16/2009: ULURU INC. PRESENTS RESULTS OF FIRST RANDOMIZED CLINICAL TRIAL FOR ALTRAZEAL™ AT THE SYMPOSIUM ON ADVANCED WOUND CARE (SAWC) FALL MEETING IN WASHINGTON D.C.
(Click here to read more)

08/14/2009: ULURU INC. REPORTS SECOND QUARTER 2009 FINANCIAL RESULTS
(Click here to read more)

07/29/2009: ULURU INC. TO PRESENT ALTRAZEAL™ CLINICAL EVIDENCE AT THE AMERICAN PODIATRIC MEDICAL ASSOCIATION (APMA) ANNUAL SCIENTIFIC MEETING IN TORONTO, CANADA
(Click here to read more)

07/27/2009: ULURU INC. ANNOUNCES STATUS OF YORK NOTE RECEIVABLE
(Click here to read more)

05/15/2009: ULURU INC. REPORTS FIRST QUARTER 2009 FINANCIAL RESULTS
(Click here to read more)

05/13/2009: ULURU INC. ANNOUNCES CONFERENCE CALL TO DISCUSS FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2009 AND TO PROVIDE A BUSINESS UPDATE
(Click here to read more)

05/05/2009: ULURU INC. ANNOUNCES ALTRAZEAL™ CLINICAL EXPERIENCE PUBLISHED IN THE INTERNATIONAL WOUND JOURNAL
(Click here to read more)

04/23/2009: ULURU TO PRESENT CLINICAL EVIDENCE AND ADVANCED RESEARCH ON ALTRAZEAL AT THE SOCIETY FOR ADVANCE WOUND CARE CONFERENCE FOR 2009
(Click here to read more)

04/06/2009: ULURU INC. SIGNS OFFER LETTER TO ACQUIRE YORK PHARMA PLC.
(Click here to read more)

04/06/2009: ULURU INC. (“ULURU”) DEALING DISCLOSURE REQUIREMENTS
(Click here to read more)

04/01/2009: ALTRAZEAL™ CLINICAL EVIDENCE TO BE PRESENTED AT THE AMERICAN PROFESSIONAL WOUND CARE ASSOCIATION (APWCA) NATIONAL CLINICAL CONFERENCE 2009
(Click here to read more)

03/30/2009: ULURU INC. REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2008
(Click here to read more)

03/25/2009: ULURU INC. ANNOUNCES CONFERENCE CALL TO DISCUSS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED December 31, 2008 AND TO PROVIDE A BUSINESS UPDATE
(Click here to read more)

03/18/2009: ULURU INC. TO PRESENT ALTRAZEAL™ CLINICAL EVIDENCE AND ADVANCED THERAPEUTIC RESEARCH AT THE DIABETIC FOOT GLOBAL CONFERENCE (DFCon) 2009
(Click here to read more)

03/13/2009: ULURU INC. ANNOUNCES APPOINTMENT OF JEFFREY A. NIEZGODA, M.D., AS CHAIRMAN OF SCIENTIFIC ADVISORY BOARD.
(Click here to read more)

03/09/2009: ULURU INC. ANNOUNCES SENIOR MANAGEMENT CHANGE. PRESIDENT AND CEO RESIGNS.
(Click here to read more)

(2008 Press Releases)